# Phase 1 Naltrexone-Bupropion-Methamphetamine Interaction Study

> **NCT01359930** · PHASE1 · COMPLETED · sponsor: **National Institute on Drug Abuse (NIDA)** · enrollment: 16 (estimated)

## Conditions studied

- Methamphetamine Dependence

## Interventions

- **OTHER:** placebo
- **DRUG:** Naltrexone and Bupropion SR

## Key facts

- **NCT ID:** NCT01359930
- **Lead sponsor:** National Institute on Drug Abuse (NIDA)
- **Sponsor class:** NIH
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-08
- **Primary completion:** 2012-06
- **Final completion:** 2012-06
- **Target enrollment:** 16 (ESTIMATED)
- **Last updated:** 2017-01-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01359930

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01359930, "Phase 1 Naltrexone-Bupropion-Methamphetamine Interaction Study". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT01359930. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*